Carna Biosciences, Inc. (TYO:4572)

Japan · Delayed Price · Currency is JPY

328.00

+13.00 (4.13%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Drug Discovery Support Business		636.24M	918.24M	1.10B	889.53M	1.08B
Drug Discovery Support Business Growth		-30.71%	-16.58%	23.74%	-17.66%	0.08%
Drug Discovery Business		-	707.65M	286.05M	1.13B	53.03M
Drug Discovery Business Growth		-	147.39%	-74.64%	2027.30%	-97.51%
Total		636.24M	1.63B	1.39B	2.02B	1.13B
Total Growth		-60.87%	17.24%	-31.27%	78.02%	-64.66%

Revenue by Geography

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Japan		198.82M	223.31M	218.75M	205.06M	277.97M
Japan Growth		-10.96%	2.08%	6.67%	-26.23%	7.22%
Others		6.80M	26.33M	37.88M	17.89M	11.82M
Others Growth		-74.19%	-30.48%	111.69%	51.43%	-88.07%
United States of America		276.86M	-	-	-	-
Europe		61.29M	112.95M	72.02M	80.97M	70.85M
Europe Growth		-45.74%	56.84%	-11.05%	14.27%	-18.47%
China		92.47M	128.72M	202.92M	71.77M	114.46M
China Growth		-28.16%	-36.57%	182.74%	-37.30%	-
North America		-	1.13B	855.19M	1.64B	658.24M
North America Growth		-	32.67%	-47.91%	149.43%	-76.17%
Total		636.23M	1.63B	1.39B	2.02B	1.13B
Total Growth		-60.87%	17.24%	-31.27%	78.02%	-64.66%

Source: S&P Global Market Intelligence.